Author:
Hu Xianwen,Li Wenxin,Li Xiaotian,Li Dandan,Cai Jiong,Wang Pan
Abstract
AbstractThe objective of this study was retrospectively to analyze the clinical characteristics and 18F-FDG PET/CT findings in Meigs syndrome (MS) patients. A total of 21 patients with MS induced by ovarian stromal tumors and 69 patients with pseudo-MS caused by ovarian cancer (OC-PMS) were subjected to evaluation using 18F-FDG PET/CT. Visual and semi-quantitative methods were employed to analyze the PET/CT findings. Visual analysis included recording whether the density of the primary tumor was uniform, whether there were cystic changes and calcifications, and the location of serous fluid accumulation. Semi-quantitative analysis involved the measurement of the tumor size, SUVmax, and SUVmean. No significant difference was observed in the size and density of primary tumors between the MS group and the OC-PMS group. However, the SUVmax and SUVmean of tumors in the MS group were found to be significantly lower than those in the OC-PMS group. The amount of serous cavity effusion caused by ovarian sex cord stromal tumors was found to be unrelated to the size of the tumor, SUVmax, and SUVmean but was positively correlated with the level of Ca125. MS patients have both benign ovarian tumors and ascites and/or pleural effusion, which may be accompanied by elevated Ca125 levels. This should be considered as one of the differential diagnoses for ovarian cancer. Understanding the PET/CT features of MS can facilitate the attainment of an accurate diagnosis before surgery.
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Meigs, J. V. Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet. Gynecol. 3(5), 471–486 (1954).
2. Riker, D. & Goba, D. Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome. J. Bronchol. Interv. Pulmonol. 20(1), 48–51 (2013).
3. Negri, S., Grassi, T. & Fruscio, R. Use of staging for sex cord stromal tumours. Curr. Opin. Oncol. 34, 504–510 (2022).
4. Kristková, L. et al. Meigs syndrome. Klin. Onkol. 35(3), 232–234 (2022).
5. Krenke, R. et al. Pleural effusion in Meigs’ syndrome-transudate or exudate? Systematic review of the literature. Medicine 94(49), e2114 (2015).